Boehringer Ingelheim is a global, research-driven pharmaceutical company committed to improving human and animal health through innovation. With a strong focus on developing breakthrough therapies in areas such as respiratory diseases, cardiovascular conditions, oncology, and metabolic disorders, the company aims to address unmet medical needs and enhance patient outcomes. Founded in 1885, Boehringer Ingelheim remains family-owned, fostering a long-term vision for sustainable healthcare solutions. Through its dedication to scientific excellence and collaboration, the company supports initiatives that drive medical advancements and promote diversity in research. 

For more information please visit: https://www.boehringer-ingelheim.com